Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain

ML Zhao, HS Suh - Neuropathology and applied neurobiology, 2009 - Wiley Online Library
Aims: Microglia are involved in neurodegeneration, are prime targets for anti‐inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

M Cosenza-Nashat, ML Zhao, HS Suh… - Neuropathology & …, 2009 - search.ebscohost.com
Aims: Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

[HTML][HTML] Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human …

M Cosenza-Nashat, ML Zhao, HS Suh… - Neuropathology and …, 2009 - ncbi.nlm.nih.gov
Aims Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain

M Cosenza-Nashat, ML Zhao… - Neuropathology …, 2009 - pubmed.ncbi.nlm.nih.gov
Aims Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

[PDF][PDF] Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human …

M Cosenza-Nashat, ML Zhao, HS Suh… - Neuropathol Appl …, 2008 - academia.edu
Aims—Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

[引用][C] Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human …

M Cosenza-Nashat, ML Zhao, HS Suh… - Neuropathology and …, 2009 - cir.nii.ac.jp
Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes
based on immunohistochemical localization in abnormal human brain | CiNii Research CiNii …

[引用][C] Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human …

M COSENZA-NASHAT, ML ZHAO… - Neuropathology …, 2009 - pascal-francis.inist.fr
Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes
based on immunohistochemical localization in abnormal human brain CNRS Inist Pascal-Francis …

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

M Cosenza-Nashat, ML Zhao, HS Suh… - Neuropathology and …, 2008 - europepmc.org
Aims Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain

M Cosenza-Nashat, ML Zhao… - Neuropathology …, 2009 - einstein.elsevierpure.com
Aims: Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

M Cosenza-Nashat, ML Zhao, HS Suh… - Neuropathology and …, 2008 - europepmc.org
Aims Microglia are involved in neurodegeneration, are prime targets for anti-inflammatory
therapy and are potential biomarkers of disease progression. For example, positron …